Pharmac have advised of shortages of the following medicines in New Zealand:

• Olanzapine depot injections: Supply issue (updated 15 December 2023)
• Prochlorperazine (Nausafix): Supply Issue (updated 27 November 2023)
• Clomipramine 25 mg tablets: Supply issue (updated 16 November 2023)
• Methylphenidate ER tablets: Supply issue (updated 22 December 2023)
• Imipramine (Tofranil) tablets 25 mg: Supply issue (updated 8 December 2023)
• Naltrexone hydrochloride 50 mg: Supply issue (updated 22 November 2023)
• Prazosin (1 mg, 2 mg, 5 mg): Supply issue (updated 14 December 2023)
• Prazosin (1 mg, 2 mg, 5 mg): Supply issue (updated 14 December 2023)

The College has also been advised of shortages in Australia of the following medicines:

• Olanzapine (as pamoate monohydrate) 210mg powder for injection vial with diluent vial: Medicine shortage (5 October 2023 to 15 April 2024)
• Olanzapine (as pamoate monohydrate) 300mg powder for injection vial with diluent vial: Medicine shortage (5 October 2023 to 15 April 2024)
• Olanzapine (as pamoate monohydrate) 405mg powder for injection vial with diluent vial: Medicine shortage (5 October 2023 to 15 April 2024)
• Vyvanse (lisdexamfetamine dimesilate) 30mg (7 August 2023 - 7 March 2024)
• Vyvanse (lisdexamfetamine dimesilate) 50mg (3 November 2023 – 7 March 2024)
• Vyvanse (lisdexamfetamine dimesilate) 60mg (18 December 2023 – 19 April 2024)

Members will be advised as further details regarding the shortages are made available.